✦ LIBER ✦

501 Jab1/CSN5 as a Novel Target to Overcome the Resistance to Trastuzumab in Her2-positive Breast Cancer

✍ Scribed by Vu, T.; Zhang, Q.; Tian, L.; Shackleford, T.; Kute, T.; Claret, F.X.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

415 Investigating the Role of HER4 in Re

✍ Nafi, S. Mohd; Kong, A.; Gijsen, M.; Kramer-Marek, G.; Capala, J. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Targeting fatty acid synthase-driven lip

✍ Javier A. Menendez; Luciano Vellon; Ruth Lupu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Erratum to: Trastuzumab: a review of its

✍ KP Garnock-Jones, GM Keating, LJ Scott 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 49 KB

315 The corepressor-associated protein T

✍ S. Reineri; S. Cutrupi; A. Panetto; L. Ricci; A. Lykkesfeldt; M. De Bortoli 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Higher efficacy of letrozole in combinat

✍ J. Huober; P.A. Fasching; M. Barsoum; L. Petruzelka; D. Wallwiener; C. Thomssen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 350 KB

PERSEPHONE is a randomised phase III con

✍ Earl, Helena; Cameron, David; Miles, David; Wardley, Andrew; Ogburn, Emma; Valli 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 40 KB